AMMF’s Hybrid 2024 European Cholangiocarcinoma Conference
All presentations from AMMF’s 3-day European Cholangiocarcinoma Conference held 08-10 May 2024 are now available here to watch again. Simply click on the topic title to see that presentation.
Poster presentations are available here.
| Topic | Presenter |
|---|---|
| DAY ONE – PATIENT AND CARER SESSIONS | |
| Overview of CCA, what it is, how it might be diagnosed | Professor Shahid A Khan Imperial College Healthcare NHS Trust & Imperial College London |
| Research and the hidden role of pathology in the CCA patient’s clinical journey | Dr Tim Kendal University of Edinburgh |
| The microbiome, what we think its importance is in CCA, and the ABC-12 study | Dr Mairéad McNamara University of Manchester and The Christie NHS Foundation Trust, Manchester. |
| Question time | Panel |
| My Journey with Cholangiocarcinoma | Andy Clay CCA Patient Advocate and AMMF Discussion Forum Moderator |
| Liquid biopsies for faster diagnosis of pancreatic and biliary tract cancers: ACCESS 2024 update | Dr Naureen Starling Royal Marsden Hospital, London |
| Molecular profiling, what is this, how is it carried out, what it can show and what the findings might mean | Dr Matt Evans Central and South Genomic Laboratory Hub and University Hospital Southampton |
| Targeted therapies / Immunotherapies – what are they, how are they different, and clinical trials | Professor John Bridgewater UCL Cancer Institute, University College London |
